Holobiome selected for $100,000 One Mind investment
The company joined One Mind’s 2024 mental health accelerator cohort.
Holobiome was selected for a $100,000 investment from One Mind on March 4, 2024.
At the time of the announcement, the company was developing microbiome-based products and therapies, including research into gut–brain biology. The programme paired its investment with mentoring, business development and fundraising support.